Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
The Menstrual Cycle01:19

The Menstrual Cycle

The menstrual cycle is a recurrent sequence of changes in the uterine endometrium, specifically its functional layer, the stratum functionalis. This cycle prepares the uterus for potential pregnancy. This cycle typically spans 21–35 days, averaging 28 days, and aligns with the ovarian cycle, regulated by fluctuating levels of ovarian hormones, primarily estrogen and progesterone.
The menstrual phase occurs from days 1 to 5 and involves the shedding of the stratum functionalis, as a uterine...
Menses Phase01:18

Menses Phase

The uterine cycle begins with the menstrual phase, which is considered day one of the cycle and typically lasts about five days. This phase is characterized by the degeneration and shedding of the stratum functionalis, the functional layer of the endometrium.
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Secretory Phase01:19

Secretory Phase

The secretory phase of the menstrual cycle, spanning from day 14 to 28 in a typical 28-day cycle, is a period of significant physiological changes in the female reproductive system. This phase commences immediately after ovulation and is characterized by the preparation of the endometrium for potential embryo implantation.
Following ovulation, the corpus luteum, a temporary endocrine structure, produces progesterone and estrogens. These hormones stimulate the growth and coiling of endometrial...
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of active travel interventions in the UK on disadvantaged population groups and their potential to reduce health inequalities: systematic review.

Journal of epidemiology and community health·2026
Same author

How effective are remote and/or digital interventions as part of alcohol and drug treatment and recovery support? A systematic review and meta-analysis.

Addiction (Abingdon, England)·2025
Same author

Cost-effectiveness of Microsoft Academic Graph with machine learning for automated study identification in a living map of coronavirus disease 2019 (COVID-19) research.

Wellcome open research·2024
Same author

Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI).

The Cochrane database of systematic reviews·2021
Same author

Cyberbullying and Children and Young People's Mental Health: A Systematic Map of Systematic Reviews.

Cyberpsychology, behavior and social networking·2020
Same author

Pain relief for women undergoing oocyte retrieval for assisted reproduction.

The Cochrane database of systematic reviews·2018

Related Experiment Video

Updated: Jun 23, 2026

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis
05:36

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis

Published on: October 4, 2024

Premenstrual syndrome.

Irene Kwan1, Joseph Loze Onwude

  • 1Royal College of obstetricians and gynaecologists, London, UK.

BMJ Clinical Evidence
|May 21, 2009
PubMed
Summary

This systematic review evaluates treatments for premenstrual syndrome (PMS). It found 52 studies on interventions like drugs, therapies, and supplements, assessing their effectiveness and safety.

Area of Science:

  • Gynecology
  • Evidence-Based Medicine

Background:

  • Premenstrual symptoms affect 95% of women, with severe premenstrual syndrome (PMS) impacting 5%.
  • Lack of standardized symptom assessment hinders treatment efficacy data synthesis.
  • The cyclical nature of PMS complicates randomized controlled trials (RCTs).

Purpose of the Study:

  • To systematically review the effects of various interventions for premenstrual syndrome (PMS).
  • To evaluate drug, hormonal, psychological, physical, dietary, and surgical treatments for PMS.
  • To assess the effectiveness and safety of interventions based on GRADE evaluation.

Main Methods:

  • Conducted a systematic review of medical literature up to November 2006.
  • Searched databases including Medline, Embase, and The Cochrane Library.

More Related Videos

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation
09:49

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation

Published on: August 13, 2015

Related Experiment Videos

Last Updated: Jun 23, 2026

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis
05:36

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis

Published on: October 4, 2024

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation
09:49

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation

Published on: August 13, 2015

  • Included harms alerts from regulatory agencies like the FDA and MHRA.

    • Main Results:

    • Included 52 systematic reviews, RCTs, or observational studies.
    • Performed a GRADE evaluation to assess the quality of evidence for interventions.
    • Identified numerous interventions for PMS, including acupuncture, SSRIs, and hormonal therapies.

    Conclusions:

    • Presents information on the effectiveness and safety of diverse PMS interventions.
    • Lists evaluated treatments such as cognitive behavioral therapy, NSAIDs, and oral contraceptives.
    • Highlights the need for standardized assessment in PMS research.